Pharsight, a St. Louis, Mo.-based software firm, said this week that Tobira Therapeutics has selected PKS Online to support its HIV drug development efforts.
Tobira will use the software to analyze, manage, and report data for its HIV drug candidate cenicriviroc, an antagonist of both CCR5, a co-receptor that’s required for HIV infection, and CCR2, a co-receptor that is involved in a number of metabolic and cardiovascular diseases. The drug is currently in Phase 2 clinical development.
David Martin, Tobira's senior vice president of drug development and regulatory affairs, said that PKS Online "[eliminates] the need for deployment, validation, and management of an in-house system."
"With PKS Online, I have real-time visibility and streamlined access to time-critical analyses and study results, available on my desktop, to readily share with our management team, scientific advisors, and other key stakeholders," he said in a statement.
PKS Online is a software-as-a-service implementation of Pharsight Knowledgebase Server, an enterprise data management system for storing and tracking pharmacokinetic and pharmacodynamic data and analyses.
Among other features, the system lets users export studies in the Clinical Data Interchange Standards Consortium format for regulatory submission as well as simplify data-management tasks required to create multi-study analyses and prepare pharmacometric models.